Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1195P is a pseudogene located on human chromosome 4 that is related to the U6 small nuclear RNA (snRNA) gene family[5][3][1]. The U6 snRNA genes encode functional non-coding RNAs involved in the spliceosome complex, essential for the splicing of pre-messenger RNA[6]. However, as a pseudogene, RNU6-1195P is a non-functional sequence derived from the active U6 snRNA gene through retrotransposition, specifically via LINE-1 (L1)-mediated processes, resulting in a genomic copy that does not produce a functional RNA product[4]. Such pseudogenes are common in vertebrate genomes and may serve as evolutionary markers but have no established biological, disease, or therapeutic relevance[4][6]. In summary, RNU6-1195P is a small nuclear RNA pseudogene and not a functional or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1195, pseudogene (RNU6-1195P).